Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS-Reference-Cited by-同舟云学术

Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS

Published:2017-08-31 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ochi Tsunehiro,Kawaguchi Takumi,Nakahara Takashi,Ono Masafumi,Noguchi Shuhei,Koshiyama Yuichi,Munekage Kensuke,Murakami Eisuke,Hiramatsu Akira,Ogasawara Mitsunari,Hirose Akira,Mizuta Hiroshi,Masuda Kosei,Okamoto Nobuto,Suganuma Narufumi,Chayama Kazuaki,Yamaguchi Masahiro,Torimura Takuji,Saibara Toshiji

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-09256-4.pdf

Reference31 articles.

1. Matteoni, C. A. et al. Nonalcoholic fatty liver diseases: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419 (1999).

2. Ono, M. & Saibara, T. Clinical features of nonalcoholic steatohepatitis in Japan: evidence from literature. J Gastroenterol. 41, 725–732 (2006).

3. Reddy, S. K. et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. HEPATOLOGY 55, 1809–1819 (2012).

4. Chitturi, S. et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 35, 373–379 (2002).

5. Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. HEPATOLOGY 37, 917–923 (2003).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis;Communications Biology;2024-03-22

2. Liver Metabolomics Analysis Revealing Key Metabolites Associated with Different Stages of Nonalcoholic Fatty Liver Disease in Hamsters;Combinatorial Chemistry & High Throughput Screening;2023-10-05

3. Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease;Journal of Pharmacology and Experimental Therapeutics;2022-08-06

4. Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease;JAMA Network Open;2022-02-23

5. Glucose Concentrations from Continuous Glucose Monitoring Devices Compared to Those from Blood Plasma during an Oral Glucose Tolerance Test in Healthy Young Adults;International Journal of Environmental Research and Public Health;2021-12-09